Group One Trading’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.7K Sell
14,500
-6,300
-30% -$21.1K ﹤0.01% 5525
2025
Q4
$82.8K Sell
20,800
-22,400
-52% -$99.1K ﹤0.01% 5156
2025
Q3
$163K Buy
43,200
+43,100
+43,100% +$146K ﹤0.01% 4896
2025
Q2
$242 Buy
+100
New +$136 ﹤0.01% 7727
2022
Q3
Sell
-2,300
Closed -$26K 7827
2022
Q2
$26K Sell
2,300
-21,700
-90% -$260K ﹤0.01% 6084
2022
Q1
$390K Buy
24,000
+20,900
+674% +$536K ﹤0.01% 4076
2021
Q4
$147K Buy
3,100
+700
+29% +$42K ﹤0.01% 5390
2021
Q3
$174K Buy
2,400
+2,300
+2,300% +$166K ﹤0.01% 5326
2021
Q2
$8K Buy
+100
New +$6.6K ﹤0.01% 7600

Other funds holding NBP

Group One Trading's NBP Position: Q1 2026 in Review

Group One Trading sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 3,963 shares — an estimated $13.3K sold.

Group One Trading first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $289K in Q2 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Group One Trading reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,963 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $13.3K.
  • Group One Trading first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
  • Group One Trading's NovaBridge Biosciences American Depositary Shares position peaked at $289K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.